IDEAS home Printed from https://ideas.repec.org/a/aph/ajpbhl/200191138-42_3.html
   My bibliography  Save this article

Prevalence of hepatitis C among injection drug users in England and Wales: Is harm reduction working?

Author

Listed:
  • Hope, V.D.
  • Judd, A.
  • Hickman, M.
  • Lamagni, T.
  • Hunter, G.
  • Stimson, G.V.
  • Jones, S.
  • Donovan, L.
  • Parry, J.V.
  • Gill, O.N.

Abstract

Objectives. This study sought to establish the prevalence of hepatitis C antibodies (anti-HCV) and hepatitis B antibodies (anti-HBc) among injection drug users in England and Wales. Methods. A voluntary cross-sectional survey collected oral fluid samples and behavioral information; 2203 injectors were recruited through drug agencies, and 758 were recruited in the community. Results. Prevalence was 30% for anti-HCV, 21% for anti-HBc, and 0.9% for HIV antibodies. Anti-HCV prevalence rates were significantly greater among those with longer injecting careers, those in older age groups, those residing in London, those recruited in drug agencies, those positive for anti-HBc, and those with a previous voluntary HIV test. Conclusions. Anti-HCV prevalence rates among injectors in England and Wales, where comprehensive harm reduction programs exist, are lower than rates in other industrialized countries.

Suggested Citation

  • Hope, V.D. & Judd, A. & Hickman, M. & Lamagni, T. & Hunter, G. & Stimson, G.V. & Jones, S. & Donovan, L. & Parry, J.V. & Gill, O.N., 2001. "Prevalence of hepatitis C among injection drug users in England and Wales: Is harm reduction working?," American Journal of Public Health, American Public Health Association, vol. 91(1), pages 38-42.
    • Handle: RePEc:aph:ajpbhl:2001:91:1:38-42_3
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:aph:ajpbhl:2001:91:1:38-42_3. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Christopher F Baum (email available below). General contact details of provider: https://www.apha.org .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.